Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

PHASE3CompletedINTERVENTIONAL
Enrollment

2,625

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

May 31, 2007

Conditions
Alzheimer Disease
Interventions
DRUG

Naproxen Sodium (Aleve)

DRUG

Celecoxib (Celebrex)

Trial Locations (6)

14620

University of Rochester, Rochester

21287

Johns Hopkins University, Baltimore

33617

Roskamp Institute Memory Clinic, 10770 N. 46th Street, Tampa

85351

Sun Health Research Institute, Sun City

98108

Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle

02118

Boston University School of Medicine, Boston

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

VA Puget Sound Health Care System

FED

collaborator

University of Washington

OTHER

collaborator

Johns Hopkins University

OTHER

lead

Seattle Institute for Biomedical and Clinical Research

OTHER

NCT00007189 - Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT) | Biotech Hunter | Biotech Hunter